About Revvity
Here's Why You Should Retain Revvity Stock in Your Portfolio for NowZacks Investment ResearchSep 29, 9:12 AM ETNeutral
Zacks Rank #3 (Hold) rating reflects balanced outlook. Strong growth drivers (diagnostics +11% organic growth, AI demand, Human Cell Design deal, strong product innovation) are offset by near-term headwinds (China divestiture uncertainty, uneven academic demand, non-recurring tariff benefits supporting margins). Stock has significantly outperformed market YTD (+56.1%), suggesting positive momentum but current rating suggests limited upside from current levels.
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?Zacks Investment ResearchSep 16, 5:14 AM ET▲ Positive
Strong 9.1% single-session jump driven by positive AI demand commentary, improved backlog, favorable analyst actions, and strategic acquisition of Human Cell Design. Expected earnings growth of 8.5% YoY supports near-term strength. Zacks Rank #2 (Buy) rating.
Also mentions RVTY
Articles that tag RVTY but are mainly about other companies.
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion OpportunityGlobeNewswire Inc.Sep 30, 4:56 AM ETNeutral
Listed as market participant but no specific products, partnerships, or recent developments mentioned in the article.
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsightGlobeNewswire Inc.Sep 22, 1:00 PM ET▲ Positive
Listed as a key player in the Alzheimer's disease biomarker market, benefiting from growing demand for diagnostic infrastructure and molecular diagnostic technologies.
Epigenetics Market Intelligence Report 2026: Strong Demand from Oncology, Precision Medicine, Pharmaceutical Research, and Liquid-Biopsy DevelopmentGlobeNewswire Inc.Sep 9, 4:41 AM ET▲ Positive
Identified as a leading provider in the epigenetics market, positioned to benefit from expanding applications in oncology, precision medicine, and pharmaceutical research.
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market ShareGlobeNewswire Inc.Sep 4, 5:48 AM ET▲ Positive
Listed as a key market player positioned to benefit from the growing multiplex assays market and increasing adoption of high-plex platforms and AI-enabled data interpretation.
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)GlobeNewswire Inc.Jun 24, 3:30 PM ET▲ Positive
Key player in the laboratory equipment services market positioned to benefit from growing demand for calibration, validation, and maintenance services across pharmaceutical and diagnostic sectors.
Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor IntelligenceGlobeNewswire Inc.Feb 27, 9:48 AM ET▲ Positive
Listed as a major company in the cord blood banking market, positioned to benefit from technological advancements and market expansion.
